Fludex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fludex

Quick Facts

Property Description
Active ingredient Fluconazole
Form Capsule, tablet, oral suspension, solution for infusion
Pharmacological class Systemic Antifungal (Triazole Derivative)
Common use Treating fungal infections (mycoses)
Origin Synthetic compound

What Type of Medicine is Fludex? (Identity and Classification)

Fludex is a medicine containing the single active substance Fluconazole, classifying it as a synthetic triazole derivative belonging to the systemic antifungal pharmacological class. This means the drug is specifically engineered to target and combat infections caused by various types of fungi rather than bacteria or viruses.

The designation of systemic antifungal indicates that the medicine is absorbed into the bloodstream and circulates throughout the body. Fluconazole is clinically recognized for its excellent oral bioavailability and effectiveness against common fungal pathogens. This efficient oral absorption is a key differentiating factor, enabling the medicine to reach deep-seated infections effectively. As a synthetic compound, the substance's therapeutic properties are precisely controlled to target fungal pathogens.


What Forms is Fludex Supplied In? (Composition and Forms)

Fludex is a single active ingredient preparation that is supplied in several forms to suit different therapeutic needs, including oral capsules, tablets, powder for oral suspension, and a sterile solution for infusion. This variety in form is essential for comprehensive patient care.

To ensure necessary therapeutic flexibility, the medicine is available in both common oral forms and an intravenous (IV) infusion solution. Fluconazole is included on the list of essential medicines in both capsule and injection form, confirming the importance and versatility of both oral and IV routes for administering this key antifungal medication worldwide.


What Is Fludex Generally Used For? (High-Level Purpose)

The general purpose of Fludex is to disrupt and manage infections caused by pathogenic fungi (known medically as mycoses) within the human body. Its active ingredient, Fluconazole, works by interfering with a substance vital for the fungus’s structural integrity, thereby hindering its ability to grow and function.

This action allows the drug to exert a fungistatic effect, which means it effectively stops the propagation of the fungal organisms. For example, it is pharmacologically confirmed to be suitable for controlling infections originating from the Candida species. By systemically circulating and targeting the core structural weakness of the fungal cell, Fludex provides essential internal support in overcoming the burden of fungal infection.

Regulatory References

  1. World Health Organization (WHO)
  2. WHO Essential Medicines List

What side effects are possible with Fludex?

Possible side effects and safety information

The safety profile for Fludex (Fluconazole) is formally documented in government regulatory sources, classifying potential adverse reactions by frequency and the body system affected. These classifications are based on observed data from clinical use and post-marketing surveillance.

Adverse Reaction Classifications

Side effects are categorized by frequency in official labels:

  • Common Reactions (ge 1/100 to <1/10): Typically include nervous system effects such as headache, and gastrointestinal issues such as nausea, vomiting, diarrhoea, and abdominal pain. Elevated liver enzyme levels are also classified as common.
  • Uncommon Reactions (ge 1/1,000 to <1/100): Examples include anaemia, decreased appetite, somnolence, dizziness, myalgia (muscular pain), and skin reactions like urticaria or increased sweating.

Serious Safety Considerations

The regulatory profile highlights several serious adverse reactions that are classified as rare (ge 1/10,000 to <1/1,000). These include severe hepatotoxicity, which can lead to hepatic failure, and severe cutaneous reactions, such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Additionally, the label notes the potential for cardiac rhythm changes, specifically QT interval prolongation, which can lead to Torsade de Pointes.

Population and Exposure Notes

Official documents indicate that the medicine should be used with caution in patients with pre-existing renal or hepatic impairment, as elimination is predominantly renal and liver monitoring is required. Severe cutaneous reactions have been noted as sometimes following prolonged use. The medicine is contraindicated in individuals with a known hypersensitivity to azole antifungals and with co-administration of certain medications that prolong the QT interval.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes specific manifestations and required actions for a suspected overdose of Fludex (Fluconazole). If an overdose is suspected, immediate medical attention is required to institute supportive care and monitoring.


Documented Overdose Manifestations

System Officially Documented Findings
Central Nervous System (CNS) Reports include manifestations such as hallucination and paranoid behavior
Cardiovascular Potential for QT prolongation and life-threatening Torsades de pointes

Emergency Actions and Management

In the event of an overdose, symptomatic and supportive treatment must be instituted immediately. According to regulatory documents, no specific antidote is known for Fludex. Management procedures officially described include the consideration of gastric lavage to limit absorption. Due to the risk of serious cardiac events, ECG monitoring and hospital observation are necessary.

Since the active substance is largely excreted in the urine, one officially documented method for elimination is a 3-hour hemodialysis session, which has been shown to decrease plasma concentrations by approximately 50% in the clinical setting.

Therapeutic Uses of Fludex

What Fludex Treats: Main Uses and Benefits

The medicine is commonly used to help with conditions involving inflammatory or irritative processes. It is relevant in contexts marked by increased discomfort related to inflammatory or irritative states across several body systems.

Treating Common Fungal Infections and Symptom Relief

Fludex is generally used to address symptoms related to physical discomfort and conditions associated with acute or disruptive episodes. It is applied across domains where additional symptomatic support is needed to help manage symptoms that interfere with daily functioning. This provides support that helps ease the overall symptom load and contributes to improved comfort during periods of heightened symptoms.

“This medication is applied in situations where additional management of discomfort is required, helping to ease the overall burden of symptoms.”

Quick Fact: Supports Symptoms that Interfere with Daily Functioning

Managing Systemic Discomfort and Symptom Management

The medication is also applied in clinical settings that involve acute or unstable symptom patterns. Furthermore, it may be used across domains where short-term symptom management is appropriate in contexts involving heightened systemic burden. This application assists with maintaining functional stability and supports the patient during difficult episodes.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Fludex? (Official Eligibility Status)

The population eligibility for Fludex (Fluconazole) is defined by official regulatory documentation, outlining groups for whom use is permitted, restricted, or absolutely prohibited.

Eligibility Scope Regulatory Status
Populations for whom use is contraindicated Absolute prohibition for patients with hypersensitivity to fluconazole or other azole antifungals. Contraindicated when co-administered with specific QT-prolonging drugs (e.g., cisapride, pimozide, quinidine) and Terfenadine at high daily doses (ge 400 mg) [Source: FDA / EMA].
Age-Related Eligibility Adults are approved for use. Pediatric use is established, though dosing is conditional on age and weight. Older adults typically require no dose change, provided kidney function is normal [Source: NIH / FDA].
Organ Function Status Use is conditional in patients with renal impairment (kidney dysfunction) and requires mandated dose adjustment. Use requires caution and monitoring in patients with hepatic impairment (liver dysfunction) [Source: EMA / NIH].
Reproductive Status Pregnancy and lactation use is generally not recommended, especially for high-dose or prolonged regimens, unless the potential benefit outweighs the risk in severe, life-threatening infections [Source: FDA / NIH].

The official eligibility profile is structured around absolute non-eligibility (contraindications) and conditional use mandates, ensuring that patients with compromised renal or hepatic function receive necessary regulatory caution and monitoring during treatment.

What should I know about interactions with other medicines?

Interaction Scope

Classification Medicinal Products Listed
Formal Contraindications Pimozide, Cisapride, Astemizole, Quinidine, Erythromycin, and Terfenadine (at doses of 400 mg/day or greater).
Exposure-Altering Agents Warfarin, Rifampicin, Oral Contraceptives, Statins (e.g., Atorvastatin, Simvastatin), Immunosuppressants (e.g., Cyclosporine, Tacrolimus), and Tofacitinib.

The official regulatory interaction profile for Fludex is defined by its role as a potent inhibitor of Cytochrome P450 isoenzyme CYP2C9 and a moderate inhibitor of CYP3A4 and CYP2C19. This mechanistic basis explains why co-administration with other medicines that are substrates of these enzymes may result in a documented increase in their plasma concentrations (AUC/Cmax).

The co-administration with agents such as Rifampicin is documented to cause a reduction in the systemic exposure of Fludex itself. This profile includes contraindications for co-use with several medicines, primarily due to the risk of QTc interval prolongation and severe cardiac events (e.g., Torsades de Pointes).

Fludex absorption is not affected by food intake, and the medicine may be taken without regard to meals. Co-ingestion with alcohol is generally advised to be avoided due to the shared potential for adverse effects on the liver. The disposition of the medicine is affected by renal function, which is a factor to consider in interactions, and pre-existing hepatic impairment may further increase risk.

Mechanism of Action

How Fludex Works

The mechanism of Fludex (Fluconazole) is centered on the precise biochemical disruption of the fungal cell's integrity, ensuring a high degree of selectivity.

Fludex operates by acting within the domain of enzyme-mediated signaling essential for fungal structural integrity. It functions as a highly selective inhibitor of the enzyme lanosterol 14-alpha demethylase (CYP51) found in the fungal organism. This targeted action modifies the early molecular steps in the ergosterol biosynthesis pathway which, through a cascade effect, compromises the organism's ability to maintain cell structure.

By blocking the synthesis of the vital structural component ergosterol while simultaneously causing toxic precursors to accumulate, the drug initiates a signaling sequence that leads to downstream cellular effects. The result is a defective and permeable fungal cell membrane, leading to a fungistatic (growth-limiting) physiological state within the affected pathways. This core mechanism, however, is subject to constraints, including the fungal cell's ability to engage drug efflux transporters (CDR1, MDR1) which suppress the drug's effective concentration at the target site.

Dosage and Administration Information

Fludex (Indapamide) is a prescription medicine, available as standard tablets (e.g., 2.5 mg) and prolonged-release tablets (e.g., 1.5 mg SR). It is typically prescribed to treat essential hypertension (high blood pressure) and edema (fluid retention) associated with congestive heart failure.

Administration and Dosage

The dosage of Fludex is individualized based on the patient's condition, age, and response to therapy. Patients must strictly follow the dosing schedule prescribed by their healthcare provider.

  • Timing: Fludex is generally taken once daily, preferably in the morning. Taking the dose too late in the day may result in increased nighttime urination.
  • Consumption: Tablets should be swallowed whole with a glass of water, with or without food. Do not chew, crush, or break prolonged-release tablets, as this can interfere with the controlled release mechanism and the proper functioning of the medication.
Condition Usual Initial Adult Daily Dose Typical Maximum Daily Dose
Hypertension 1.25 mg or 1.5 mg SR 5 mg
Edema (Heart Failure) 2.5 mg 5 mg

Important Considerations

  • Missed Dose: If a dose is missed, take it as soon as it is remembered. However, if it is nearly time for the next scheduled dose, skip the missed dose and resume the regular dosing schedule. Do not take a double dose to compensate for a forgotten one.
  • Duration of Therapy: Treatment for conditions like high blood pressure is often long-term, possibly for life. Continue taking Fludex regularly, even if you feel well, unless advised otherwise by a doctor. Abrupt cessation can lead to a rise in blood pressure, increasing the risk of cardiovascular events.

Recent Clinical Evidence

Research evidence / Overview of studies for Fludex

The research evidence for Fludex (Fluconazole) is primarily derived from multi-center studies including Randomized Controlled Trials (RCTs), systematic reviews, and meta-analyses that have been evaluated by health authorities globally as part of the authorization process. These studies have primarily focused on measuring the outcomes of clearing fungal organisms from the body and tracking infection rates in high-risk patients. Research helps show what has been observed so far in specific patient groups and provides context but not individual predictions.


Evidence for use in Systemic Fungal Infections

The agent was studied in patients with systemic infections caused by susceptible Candida species (Candidiasis) and Cryptococcal Meningitis. These trials monitored primary outcomes such as mycological clearance (the finding that the fungus is eliminated from the bloodstream) and overall patient survival over a defined observation period. Research describes that the agent was evaluated in studies where high concentration in the central nervous system was a focus.

Research on Cryptococcal Meningitis Treatment Phases

Studies explored the use of the medicine in immunocompromised adults with Cryptococcal Meningitis following initial, intensive treatment. The research examined outcomes related to prevention of relapse or recurrence, monitoring patients over observation periods that lasted many months. Research also described that its use alone during the initial, acute infection phase was associated with lower measured fungal clearance rates from the cerebrospinal fluid (CSF) compared to combination regimens.


Evidence for use in Preventing Fungal Infections (Prophylaxis)

Preventative use (prophylaxis) was evaluated in specific high-risk populations, including adults undergoing bone marrow transplantation and Very Low Birth Weight (VLBW) preterm infants. The primary outcomes monitored in these trials included the incidence rate of Invasive Fungal Infection (IFI) and changes in the fungal colonization rate. For infants, research highlights changes measured during the short-term study period, often showing lower measured IFI incidence rates in the groups receiving the preventative course compared to control groups.


What is Still Uncertain About Fludex Research

Research notes that its spectrum of activity does not extend to certain types of fungi, specifically molds (such as Aspergillus species). The majority of the evidence focuses on its evaluation against yeasts, such as Candida and Cryptococcus species. Furthermore, studies document that fungal resistance patterns may emerge or increase with prolonged use. The follow-up durations were limited in some trials, meaning long-term outcomes are not well characterized across the entire range of studied conditions.

Frequently Asked Questions (FAQ)

Common questions about Fludex (FAQ)

Q: Is Fludex known to affect sleep?

Official product information notes that effects on the nervous system may occur. Reported side effects include both somnolence, which is feeling drowsy or sleepy, and inability to sleep (insomnia). These are generally classified based on frequency observed during clinical use.

Q: Will taking Fludex make me need to use the bathroom more often?

The medicine’s active substance, fluconazole, is primarily eliminated from the body unchanged through the kidneys and urine. However, increased urination is not listed as a common or uncommon side effect in official regulatory documents.

Q: Is it typical to feel dizzy when first starting Fludex?

Dizziness is a possible side effect listed in the official product information. Because of this potential effect, official guidance may include cautions regarding activities like driving, based on the risk of dizziness.

Q: Is it safe to take Fludex if I have diabetes?

Official information indicates Fludex can interact with certain medications used for diabetes management, such as sulfonylureas or insulin. This interaction may potentially increase the risk of developing low blood sugar. Information regarding diabetes management and all current treatments is important for healthcare providers when determining the appropriate use of this medicine.

Q: What should I do if a side effect of Fludex feels concerning?

Regulatory documents describe the signs of serious adverse reactions, such as severe rash, peeling skin, or difficulty breathing, as circumstances where emergency care is indicated. For other side effects, regulatory information states that a healthcare provider can offer guidance.

Q: Are there published studies about Fludex?

Yes, the effectiveness and safety of the medicine have been reviewed by health authorities globally as part of the authorization process. This review includes evidence from clinical trials, such as Randomized Controlled Trials (RCTs) and systematic reviews.

Q: Does Fludex interact with over-the-counter pain relievers?

Official drug labels mention specific interactions with common medications. For instance, the effects of ibuprofen, a frequent over-the-counter pain reliever, may be increased when taken at the same time as Fludex. Official labels state that information regarding all concurrent medications, including non-prescription drugs, is necessary for appropriate use.

Q: Are there any known interactions between Fludex and alcohol?

Yes, official guidance recommends that the co-ingestion of alcohol be generally avoided while taking Fludex. This recommendation is based on the shared potential for adverse effects on the liver.

Q: Is it common for Fludex to cause muscle cramps?

Official documents list muscle pain (myalgia) as an uncommon side effect. While muscle cramps have been reported through post-marketing surveillance, a specific frequency for this symptom is not known or established in the primary regulatory information.

Q: Does Fludex affect cholesterol levels?

Yes, official regulatory documents state that Fludex may cause changes in certain blood tests. This can include an increase in blood levels of cholesterol and other fats, which is classified as a rare side effect.

Q: Can Fludex be taken with vitamin supplements?

Official drug labels indicate that information on all current medications, including any vitamin or herbal supplements, should be provided to a healthcare provider. This is due to the potential for the medicine to interact with other substances, which may affect the levels of either product in the body.

Q: Is there any research on the long-term effectiveness of Fludex?

Research documents note that while many studies have been conducted, the follow-up periods were sometimes limited in duration. This means that long-term outcomes for the medicine are not yet fully characterized across the entire range of studied conditions.

Q: How is the benefit of Fludex described in regulatory documents?

The benefit is described by its approved uses, which are for treating various fungal infections and preventing candidiasis in specific high-risk populations. Official research focuses on measurable outcomes, such as the elimination of the fungus (mycological clearance) and overall patient survival rates in relevant infection types.

Q: Does Fludex have any known impact on blood sugar?

The medicine can interact with certain oral medications used to lower blood sugar, such as insulin and sulfonylureas. This interaction has the potential to enhance the effects of those diabetes drugs, possibly increasing the risk of low blood sugar.

Q: Can Fludex affect liver enzyme levels?

Yes, the official safety profile classifies increases in blood tests of liver function (elevated liver enzyme levels) as a common side effect. Use of the medicine requires caution and monitoring in patients with pre-existing liver impairment.

Q: Can Fludex be used by people with heart conditions?

Regulatory documents advise caution when using the medicine in people with heart conditions. The drug is associated with a risk of QT prolongation, which is a change in the heart's electrical rhythm, potentially leading to serious heart rhythm problems.

Q: Can women who are planning pregnancy use Fludex?

Official labels include information that patients who are of childbearing potential are often advised to use reliable contraception during treatment. This is because the effects of the medicine on a developing fetus are not fully known, especially with higher doses or prolonged regimens.

Q: Does Fludex interact with any common antidepressant medications?

Yes, official regulatory documents list possible interactions with some antidepressant drugs. For example, Fludex can interact with medications like sertraline (an SSRI), which could increase the risk of an irregular heart rhythm.

Q: What age groups is Fludex usually prescribed to?

The medicine has established approval for use in adults and also has established pediatric use. Dosing for children is conditional on the child's age and weight, as determined by a healthcare provider.

Q: How do I know if Fludex is working for me?

Clinical trials monitored outcomes such as mycological clearance, which is the measurable elimination of the fungal organism from the body, and improvement in infection rates. The overall success of the treatment is often determined by laboratory results and changes in physical symptoms.

Q: Is Fludex considered a blood pressure medicine?

No. Official documents classify Fludex (Fluconazole) as a Systemic Antifungal (Triazole Derivative). Its therapeutic purpose is to treat or prevent infections caused by various types of fungi.

Q: Are headaches a frequent side effect of Fludex?

Yes. Headache is listed in the official safety profile as a Common Reaction, meaning it affects between 1 in 100 and 1 in 10 people who use the medication.

Q: What are the most common side effects listed in official documents for Fludex?

The official labels classify Common Reactions as those affecting up to 1 in 10 people. These typically include: headache, stomach discomfort, nausea, vomiting, diarrhoea, and elevated blood tests of liver function.

How should Fludex be stored and disposed of?

Storage Requirements (Official Regulatory Information)

Item Requirement
Temperature & Environmental Control Tablets/Dry Powder must be stored below 30 C (86 F). All forms must be protected from freezing, and tablets should be kept away from moisture and light [1.1, 1.2].
Container & Integrity Rules The medication must be kept in its original container and the container must remain tightly closed [1.2]. Do not use the medicine if the original seal over the opening is broken [1.2].
Stability After Reconstitution The oral suspension must be stored between 5 C and 30 C and discarded after 14 days (2 weeks) from the time of mixing [1.1, 1.2].
Child Safety The medicine must be stored out of the sight and reach of children [1.2].

Disposal Instructions

Unused or expired Fludex must be safely thrown away [1.2]. Disposal should follow the official FDA guidelines for safely discarding unused medicine [1.2]. Needles and sharps associated with the infusion form require specific handling; ask a healthcare provider or pharmacist for instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fludex found in:

A-Z Index: